Ensign Peak Advisors’s Axsome Therapeutics AXSM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.19M | Buy |
30,595
+15,630
| +104% | +$1.63M | 0.01% | 746 |
|
|
2025
Q1 | $1.75M | Buy |
14,965
+400
| +3% | +$46.7K | ﹤0.01% | 959 |
|
|
2024
Q4 | $1.23M | Hold |
14,565
| – | – | ﹤0.01% | 1192 |
|
|
2024
Q3 | $1.31M | Hold |
14,565
| – | – | ﹤0.01% | 1165 |
|
|
2024
Q2 | $1.17M | Hold |
14,565
| – | – | ﹤0.01% | 1183 |
|
|
2024
Q1 | $1.16M | Sell |
14,565
-735
| -5% | -$58.7K | ﹤0.01% | 1220 |
|
|
2023
Q4 | $1.22M | Hold |
15,300
| – | – | ﹤0.01% | 1232 |
|
|
2023
Q3 | $1.07M | Buy |
15,300
+4,250
| +38% | +$297K | ﹤0.01% | 1144 |
|
|
2023
Q2 | $794K | Buy |
11,050
+1,100
| +11% | +$79K | ﹤0.01% | 1423 |
|
|
2023
Q1 | $614K | Buy |
9,950
+550
| +6% | +$33.9K | ﹤0.01% | 1575 |
|
|
2022
Q4 | $725K | Buy |
9,400
+750
| +9% | +$57.8K | ﹤0.01% | 1425 |
|
|
2022
Q3 | $386K | Sell |
8,650
-2,670
| -24% | -$119K | ﹤0.01% | 1590 |
|
|
2022
Q2 | $434K | Hold |
11,320
| – | – | ﹤0.01% | 1522 |
|
|
2022
Q1 | $469K | Hold |
11,320
| – | – | ﹤0.01% | 1574 |
|
|
2021
Q4 | $428K | Buy |
+11,320
| New | +$428K | ﹤0.01% | 1677 |
|
|
2021
Q3 | – | Sell |
-11,597
| Closed | -$782K | – | 1852 |
|
|
2021
Q2 | $782K | Sell |
11,597
-6,485
| -36% | -$437K | ﹤0.01% | 1498 |
|
|
2021
Q1 | $1.02M | Hold |
18,082
| – | – | ﹤0.01% | 1417 |
|
|
2020
Q4 | $1.47M | Hold |
18,082
| – | – | ﹤0.01% | 1222 |
|
|
2020
Q3 | $1.29M | Buy |
18,082
+10,826
| +149% | +$771K | ﹤0.01% | 1191 |
|
|
2020
Q2 | $597K | Hold |
7,256
| – | – | ﹤0.01% | 1424 |
|
|
2020
Q1 | $427K | Buy |
+7,256
| New | +$427K | ﹤0.01% | 1426 |
|